Suchergebnisse - "drug development"

PubPharm (9.303)

21

Organoid models : the future companions of personalized drug development

enthalten in: Biofabrication | 2024

von Piraino, F. | Costa, M. | Meyer, M. | +5

22

Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg muscles

enthalten in: Journal of pharmacokinetics and pharmacodynamics | 2024

von Yoon, D. | Daniels, M. | Willcocks, R. | +7

23

Non-toxicity of Plant Candicidal Peptides for Mammalian Cell Lines and Galleria mellonella Model to Improving Selectivity for Clinical Use

enthalten in: International journal of peptide research and therapeutics | 2024

von Cherene, M. | Cavaco, M. | Neves, V. | +7

24

Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine-Independent and Chronic Itch

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Balzulat, A. | Zhu, W. | Flauaus, C. | +18

25

Oxytocin and vasopressin signaling in health and disease

enthalten in: Trends in biochemical sciences | 2024

von Perisic, M. | Woolcock, K. | Hering, A. | +2

26

ECLIM-SEHOP : how to develop a platform to conduct academic trials for childhood cancer

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Juan-Ribelles, A. | Bautista, F. | Cañete, A. | +28

27

Physiologically Based Biopharmaceutics Modeling (PBBM) : Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report

enthalten in: Molecular pharmaceutics | 2024

von Mackie, C. | Arora, S. | Seo, P. | +14

28

Paving the way towards medicines for women and men

enthalten in: European journal of clinical pharmacology | 2024

von Banzi, R. | Garattini, S.

29

Different Development Strategies Affecting Japan's Drug lag between Japan-Based and Foreign-Based Companies

enthalten in: Therapeutic innovation & regulatory science | 2024

von Hidaka, M. | Hanaoka, H. | Uyama, Y.

30

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo

enthalten in: Cell stem cell | 2024

von Namoto, K. | Baader, C. | Orsini, V. | +51